Author:
Mori Takehiko,Koh Hideo,Onishi Yasushi,Kako Shinichi,Onizuka Makoto,Kanamori Heiwa,Ozawa Yukiyasu,Kato Chiaki,Iida Hiroatsu,Suzuki Ritsuro,Ichinohe Tatsuo,Kanda Yoshinobu,Maeda Tetsuo,Nakao Shinji,Yamazaki Hirohito
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Armand P, Antin JH. Allogeneic stem cell transplantation for aplastic anemia. Biol Blood Marrow Transplant. 2007;13:505–16.
2. Nakao S. Guest editorial: advances in the management of acquired aplastic anemia. Int J Hematol. 2013;97:551–2.
3. Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood. 1994;84:941–9.
4. Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC, et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood. 1992;79:269–75.
5. Kahl C, Leisenring W, Deeg HJ, Chauncey TR, Flowers ME, Martin PJ, et al. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br J Haematol. 2005;130:747–51.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献